活化凝血因子 VII 成功治疗弥漫性肺泡出血 - Suppr

Suppr

超能文献

Successful treatment of diffuse alveolar hemorrhage with activated factor VII.

作者信息

Henke David, Falk Ronald J, Gabriel Don A

出版信息

Ann Intern Med. 2004 Mar 16;140(6):493-4. doi: 10.7326/0003-4819-140-6-200403160-00033.

DOI:10.7326/0003-4819-140-6-200403160-00033

PMID:15023729

Abstract

摘要

相似文献

Successful treatment of diffuse alveolar hemorrhage with activated factor VII.

Ann Intern Med. 2004 Mar 16;140(6):493-4. doi: 10.7326/0003-4819-140-6-200403160-00033.

Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.

Chest. 2003 Dec;124(6):2400-3. doi: 10.1016/s0012-3692(15)31709-8.

[Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage].

Rev Mal Respir. 2011 Jan;28(1):106-11. doi: 10.1016/j.rmr.2010.07.007. Epub 2011 Jan 11.

Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage.

Pediatr Blood Cancer. 2014 Mar;61(3):570-1. doi: 10.1002/pbc.24841. Epub 2013 Nov 5.

Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child.

Pediatr Pulmonol. 2010 Apr;45(4):411. doi: 10.1002/ppul.21178.

Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report.

Medicine (Baltimore). 2014 Sep;93(14):e72. doi: 10.1097/MD.0000000000000072.

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.

Crit Care. 2006;10(6):R177. doi: 10.1186/cc5132.

Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2007 May;13(5):622-3. doi: 10.1016/j.bbmt.2007.01.070.

Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Lung. 2015 Jun;193(3):375-9. doi: 10.1007/s00408-015-9720-z. Epub 2015 Mar 24.

Factor viia for alveolar hemorrhage in microscopic polyangiitis.

Am J Respir Crit Care Med. 2002 Nov 1;166(9):1291-2. doi: 10.1164/ajrccm.166.9.267d.

引用本文的文献

Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.

Int J Mol Sci. 2021 Jan 14;22(2):793. doi: 10.3390/ijms22020793.

Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Stem Cell Transplantation.

Front Oncol. 2020 Sep 9;10:1757. doi: 10.3389/fonc.2020.01757. eCollection 2020.

Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Medicine (Baltimore). 2020 May;99(20):e20284. doi: 10.1097/MD.0000000000020284.

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals.

Cureus. 2019 Nov 19;11(11):e6202. doi: 10.7759/cureus.6202.

Diffuse Alveolar Hemorrhage without Extrapulmonary Manifestations: A Rare Presentation of Lupus.

Am J Case Rep. 2018 Feb 28;19:218-223. doi: 10.12659/ajcr.907148.

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients.

Korean J Pediatr. 2016 Mar;59(3):105-13. doi: 10.3345/kjp.2016.59.3.105. Epub 2016 Mar 31.

Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage.

Ann Saudi Med. 2015 May-Jun;35(3):231-9. doi: 10.5144/0256-4947.2015.231.

Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Lung. 2015 Jun;193(3):375-9. doi: 10.1007/s00408-015-9720-z. Epub 2015 Mar 24.

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

J Intensive Care. 2014 Aug 27;2(1):47. doi: 10.1186/s40560-014-0047-2. eCollection 2014.

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.

Case Rep Hematol. 2014;2014:283086. doi: 10.1155/2014/283086. Epub 2014 Jul 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment of diffuse alveolar hemorrhage with activated factor VII.

作者信息

Henke David, Falk Ronald J, Gabriel Don A

出版信息

Ann Intern Med. 2004 Mar 16;140(6):493-4. doi: 10.7326/0003-4819-140-6-200403160-00033.

DOI:10.7326/0003-4819-140-6-200403160-00033

PMID:15023729

Abstract

摘要

相似文献

Successful treatment of diffuse alveolar hemorrhage with activated factor VII.

Ann Intern Med. 2004 Mar 16;140(6):493-4. doi: 10.7326/0003-4819-140-6-200403160-00033.

Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.

Chest. 2003 Dec;124(6):2400-3. doi: 10.1016/s0012-3692(15)31709-8.

[Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage].

Rev Mal Respir. 2011 Jan;28(1):106-11. doi: 10.1016/j.rmr.2010.07.007. Epub 2011 Jan 11.

Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage.

Pediatr Blood Cancer. 2014 Mar;61(3):570-1. doi: 10.1002/pbc.24841. Epub 2013 Nov 5.

Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child.

Pediatr Pulmonol. 2010 Apr;45(4):411. doi: 10.1002/ppul.21178.

Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report.

Medicine (Baltimore). 2014 Sep;93(14):e72. doi: 10.1097/MD.0000000000000072.

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.

Crit Care. 2006;10(6):R177. doi: 10.1186/cc5132.

Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2007 May;13(5):622-3. doi: 10.1016/j.bbmt.2007.01.070.

Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Lung. 2015 Jun;193(3):375-9. doi: 10.1007/s00408-015-9720-z. Epub 2015 Mar 24.

Factor viia for alveolar hemorrhage in microscopic polyangiitis.

Am J Respir Crit Care Med. 2002 Nov 1;166(9):1291-2. doi: 10.1164/ajrccm.166.9.267d.

引用本文的文献

Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.

Int J Mol Sci. 2021 Jan 14;22(2):793. doi: 10.3390/ijms22020793.

Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Stem Cell Transplantation.

Front Oncol. 2020 Sep 9;10:1757. doi: 10.3389/fonc.2020.01757. eCollection 2020.

Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Medicine (Baltimore). 2020 May;99(20):e20284. doi: 10.1097/MD.0000000000020284.

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals.

Cureus. 2019 Nov 19;11(11):e6202. doi: 10.7759/cureus.6202.

Diffuse Alveolar Hemorrhage without Extrapulmonary Manifestations: A Rare Presentation of Lupus.

Am J Case Rep. 2018 Feb 28;19:218-223. doi: 10.12659/ajcr.907148.

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients.

Korean J Pediatr. 2016 Mar;59(3):105-13. doi: 10.3345/kjp.2016.59.3.105. Epub 2016 Mar 31.

Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage.

Ann Saudi Med. 2015 May-Jun;35(3):231-9. doi: 10.5144/0256-4947.2015.231.

Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Lung. 2015 Jun;193(3):375-9. doi: 10.1007/s00408-015-9720-z. Epub 2015 Mar 24.

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

J Intensive Care. 2014 Aug 27;2(1):47. doi: 10.1186/s40560-014-0047-2. eCollection 2014.

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.

Case Rep Hematol. 2014;2014:283086. doi: 10.1155/2014/283086. Epub 2014 Jul 10.